Skip to main content
Erschienen in: Reactions Weekly 1/2018

01.11.2018 | Case report

Afatinib

Diarrhoea and cautaneous lesions: 2 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Liam C, et al. Real-World Experience of First-Line Afatinib Treatment in Patients with EGFR Mutant Advanced Non-Small Cell Lung Cancer. Journal of Thoracic Oncology 13 (Suppl.): S998-S999 abstr. P3.15-21, No. 10, Oct 2018. Available from: URL: http://doi.org/10.1016/j.jtho.2018.08.1897 [abstract] -Malaysia Liam C, et al. Real-World Experience of First-Line Afatinib Treatment in Patients with EGFR Mutant Advanced Non-Small Cell Lung Cancer. Journal of Thoracic Oncology 13 (Suppl.): S998-S999 abstr. P3.15-21, No. 10, Oct 2018. Available from: URL: http://​doi.​org/​10.​1016/​j.​jtho.​2018.​08.​1897 [abstract] -Malaysia
Metadaten
Titel
Afatinib
Diarrhoea and cautaneous lesions: 2 case reports
Publikationsdatum
01.11.2018
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2018
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-018-54281-1

Weitere Artikel der Ausgabe 1/2018

Reactions Weekly 1/2018 Zur Ausgabe

Case report

Multiple drugs

Case report

Antivirals

Case report

Osimertinib

Case report

Multiple drugs